Journal of Clinical Endocrinology & Metabolism, Vol 81, 995-997, Copyright © 1996 by Endocrine Society

ARTICLES

Decline of plasma growth hormone binding protein in old age

H Maheshwari, L Sharma and G Baumann
Center for Endocrinology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

Aging is associated with a progressive decline in GH secretion and serum insulin-like growth factor (IGF)-I levels. This change in the GH- IGF axis is thought to contribute to the changes in body composition associated with aging, such as a loss in lean body mass and an increase in adipose tissue mass. Although the decrease in GH secretion starts in the third decade of life, marked changes in muscle mass and strength become apparent only much later. To assess whether a component of GH resistance supervenes in senescence, we studied plasma GH binding protein (GHBP) levels in 50 normal subjects between the ages of 61 and 98 yr. The GHBP is a soluble, circulating ectodomain of the GH receptor (GHR); its plasma level is thought to reflect GHR levels in tissues and, hence, GH responsivity. GHBP activity in plasma declined progressively between age 60 and 98 yr. The GHBP levels in nonagenarians was about half that of persons aged 60-65. This contrasts with younger adults, where GHBP levels remain relatively stable between the ages of 20 and 60. We conclude that in advanced age. GHBP and, by inference, GHR levels, decrease, which may add an element of GH resistance to the already compromised GH secretion status, thereby further contributing to the changes in body composition and frailty in the elderly.

This article has been cited by other articles:

				H. K. Gleeson, C. A. Lissett, and S. M. Shalet Insulin-Like Growth Factor-I Response to a Single Bolus of Growth Hormone Is Increased in Obesity J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1061 - 1067. [Abstract] [Full Text] [PDF]

				M. Bondanelli, A. Margutti, M. R. Ambrosio, L. Plaino, L. Cobellis, F. Petraglia, and E. C. degli Uberti Blood Growth Hormone-Binding Protein Levels in Premenopausal and Postmenopausal Women: Roles of Body Weight and Estrogen Levels J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1973 - 1980. [Abstract] [Full Text]

				J. D. Wallace, R. C. Cuneo, R. Baxter, H. Orskov, N. Keay, C. Pentecost, R. Dall, T. Rosen, J. O. Jorgensen, A. Cittadini, et al. Responses of the Growth Hormone (GH) and Insulin-Like Growth Factor Axis to Exercise, GH Administration, and GH Withdrawal in Trained Adult Males: A Potential Test for GH Abuse in Sport J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3591 - 3601. [Abstract] [Full Text] [PDF]

				Y. Shuto, T. Nakano, N. Sanno, H. Domoto, H. Sugihara, and I. Wakabayashi Reduced Growth Hormone Receptor Messenger Ribonucleic Acid in an Aged Man with Chronic Malnutrition and Growth Hormone Resistance J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2320 - 2323. [Abstract] [Full Text]

				J.-L. Bresson, S. Jeay, M.-C. Gagnerault, C. Kayser, N. Beressi, Z. Wu, S. Kinet, M. Dardenne, and M.-C. Postel-Vinay Growth Hormone (GH) and Prolactin Receptors in Human Peripheral Blood Mononuclear Cells: Relation with Age and GH-Binding Protein Endocrinology, July 1, 1999; 140(7): 3203 - 3209. [Abstract] [Full Text]

				S. Ji, R. Guan, S. J. Frank, and J. L. Messina Insulin Inhibits Growth Hormone Signaling via the Growth Hormone Receptor/JAK2/STAT5B Pathway J. Biol. Chem., May 7, 1999; 274(19): 13434 - 13442. [Abstract] [Full Text] [PDF]

				O. Khorram, G. A. Laughlin, and S. S. C. Yen Endocrine and Metabolic Effects of Long-Term Administration of [Nle27]Growth Hormone-Releasing Hormone-(1-29)-NH2 in Age-Advanced Men and Women J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1472 - 1479. [Abstract] [Full Text] [PDF]